Insider · CIK 0001047575
Ram Mukunda
Files at IGC (IGC Pharma, Inc.). First filing -, latest -.
In brief
Ram Mukunda files SEC Form 4 as CEO and director at IGC (IGC Pharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ram Mukunda has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 15, 2024 | IGC IGC Pharma, Inc. | 300,000 0.47% of outstanding | $600k | Mar 15, 2024 | none |
Transactions
Every row this insider has filed, 32 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | IGC IGC Pharma, Inc. | GGift Common Stock | -100,000 | $0.00 | $0 | 6,775,563 | 14 d ago |
| Sep 25, 2026 | IGC IGC Pharma, Inc. | GGift Common Stock | -100,000 | $0.00 | $0 | 6,675,563 | 14 d ago |
| Jun 30, 2026 | IGC IGC Pharma, Inc. | AGrant or award Common Stock | +2,226,475 | $0.27 | $601k | 6,875,563 | Jul 1, 2026 |
| Apr 1, 2026 | IGC IGC Pharma, Inc. | MOption exercise Common Stock | +333,333 | $0.00 | $0 | 4,326,011 | Apr 6, 2026 |
| Apr 1, 2026 | IGC IGC Pharma, Inc. | MOption exercise Common Stock | +323,077 | $0.26 | $84k | 4,649,088 | Apr 6, 2026 |
| Apr 1, 2026 | IGC IGC Pharma, Inc. | MOption exercise Common Stockindirect: BY SPOUSE | +16,667 | $0.00 | $0 | 877,419 | Apr 6, 2026 |
| Apr 1, 2026 | IGC IGC Pharma, Inc. | MOption exercise Common Stockindirect: BY SPOUSE | +33,332 | $0.00 | $0 | 910,751 | Apr 6, 2026 |
| Apr 1, 2026 | IGC IGC Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -333,333 | $0.00 | $0 | 0 | Apr 6, 2026 |
| Apr 1, 2026 | IGC IGC Pharma, Inc. | MOption exercise Optionsderivative | -323,077 | $0.00 | $0 | 676,925 | Apr 6, 2026 |
| Apr 1, 2026 | IGC IGC Pharma, Inc. | MOption exercise Restricted Stock Unitsderivativeindirect: BY SPOUSE | -16,667 | $0.00 | $0 | 0 | Apr 6, 2026 |
| Apr 1, 2026 | IGC IGC Pharma, Inc. | MOption exercise Restricted Stock Unitsderivativeindirect: BY SPOUSE | -33,332 | $0.00 | $0 | 33,334 | Apr 6, 2026 |
| Feb 3, 2026 | IGC IGC Pharma, Inc. | MOption exercise Common Stockindirect: BY SPOUSE | +50,000 | $0.00 | $0 | 860,752 | Feb 4, 2026 |
| Feb 3, 2026 | IGC IGC Pharma, Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: BY SPOUSE | +16,667 | $0.00 | $0 | 16,667 | Feb 4, 2026 |
| Feb 3, 2026 | IGC IGC Pharma, Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: BY SPOUSE | +66,666 | $0.00 | $0 | 66,666 | Feb 4, 2026 |
| Oct 17, 2025 | IGC IGC Pharma, Inc. | GGift Common Stock | -100,000 | $0.00 | $0 | 3,992,678 | Oct 20, 2025 |
| Oct 17, 2025 | IGC IGC Pharma, Inc. | AGrant or award Optionsderivative | +3,000,000 | $0.00 | $0 | 3,000,000 | Oct 20, 2025 |
| Oct 17, 2025 | IGC IGC Pharma, Inc. | AGrant or award Optionsderivative | +1,500,000 | $0.00 | $0 | 1,500,000 | Oct 20, 2025 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | MOption exercise Common Stock | +333,333 | $0.00 | $0 | 2,908,093 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | MOption exercise Common Stock | +233,334 | $0.00 | $0 | 3,141,427 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | MOption exercise Common Stock | +333,334 | $0.00 | $0 | 3,474,761 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | MOption exercise Common Stock | +251,250 | $0.00 | $0 | 3,726,011 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | GGift Common Stock | -200,000 | $0.00 | $0 | 3,526,011 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | MOption exercise Common Stockindirect: BY SPOUSE | +16,667 | $0.00 | $0 | 794,085 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | MOption exercise Common Stockindirect: BY SPOUSE | +16,667 | $0.00 | $0 | 810,752 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -233,333 | $0.00 | $0 | 233,333 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -333,333 | $0.00 | $0 | 0 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -333,334 | $0.00 | $0 | 666,667 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -251,250 | $0.00 | $0 | 783,750 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | AGrant or award Optionsderivative | +1,000,002 | $0.00 | $0 | 0 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | AGrant or award Optionsderivative | +1,500,000 | $0.00 | $0 | 0 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | MOption exercise Restricted Stock Unitsderivativeindirect: BY SPOUSE | -16,667 | $0.00 | $0 | 0 | Mar 18, 2024 |
| Mar 13, 2024 | IGC IGC Pharma, Inc. | MOption exercise Restricted Stock Unitsderivativeindirect: BY SPOUSE | -16,667 | $0.00 | $0 | 33,333 | Mar 18, 2024 |
Questions about Ram Mukunda
Answered from the filings on this page, as of the latest one.
Is Ram Mukunda buying or selling?
Ram Mukunda has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ram Mukunda's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ram Mukunda has 0.
Where does Ram Mukunda file Form 4?
Ram Mukunda has filed Form 4 at IGC (IGC Pharma, Inc.) as CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.